Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cysteamine dose-ranging study in symptomatic Huntington's disease using serum BDNF
2007-002977-30Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cysteamine in Huntington disease (HD) (4 arms), sponsored by Centre Hospitalier Universitaire d'Angers. Started Aug 2008; status: active.
02
Drugs
cysteamine
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on 2007-002977-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002977-30.